Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects

Aimee K. Bence, Eric B. Anderson, Maqbool A. Halepota, Michael A. Doukas, Phillip A. DeSimone, George A. Davis, Deborah A. Smith, Kevin M. Koch, Andrew G. Stead, Steve Mangum, Carolyn J. Bowen, Neil L. Spector, Showchien Hsieh, Val R. Adams

Research output: Contribution to journal › Article › peer-review

113 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science